Filing Details
- Accession Number:
- 0001493152-22-030744
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-04 20:21:02
- Reporting Period:
- 2022-11-04
- Accepted Time:
- 2022-11-04 20:21:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444307 | Oncosec Medical Inc | ONCS | Pharmaceutical Preparations (2834) | 980573252 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1728262 | J Robert Delaversano | C/O Oncosec Medical Incorporated 24 North Main Street Pennington NJ 08534 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-11-04 | 283 | $0.37 | 22,975 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- In connection with the vesting of 1,093 RSUs on November 1, 2022, a total of 283 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.